OIG 2012 plan includes Medicare opt-outs, off-label drugs

12/30/2011 | MedPage Today (free registration)

The HHS Office of Inspector General's work plan for 2012 includes studying the number of physicians who opt out of Medicare. The OIG also will study off-label drug use in Medicare and Medicaid and whether such prescribing adheres to standards for reimbursement.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN